These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 12136610)
1. [Microvolt T wave alternans as a predictor for sudden cardiac death]. Tanno K; Katagiri T Nihon Rinsho; 2002 Jul; 60(7):1324-33. PubMed ID: 12136610 [TBL] [Abstract][Full Text] [Related]
2. Microvolt T wave alternans (MTWA)--a new non-invasive predictor of sudden cardiac death. Predescu D; Mitruţ P; Giucă A Rom J Intern Med; 2004; 42(3):647-56. PubMed ID: 16366137 [TBL] [Abstract][Full Text] [Related]
3. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545 [TBL] [Abstract][Full Text] [Related]
4. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator. Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death]. Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065 [TBL] [Abstract][Full Text] [Related]
6. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS; J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603 [TBL] [Abstract][Full Text] [Related]
7. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification]. Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786 [TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307 [TBL] [Abstract][Full Text] [Related]
13. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy. Baravelli M; Fantoni C; Rogiani S; Farina S; Anzà C; Caltabiano V; Forzani T; Salerno-Uriarte JA Int J Cardiol; 2007 Sep; 121(1):23-9. PubMed ID: 17188766 [TBL] [Abstract][Full Text] [Related]
14. Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction. Sulimov V; Okisheva E; Tsaregorodtsev D Europace; 2012 Dec; 14(12):1786-92. PubMed ID: 22849973 [TBL] [Abstract][Full Text] [Related]
15. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death. Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study. Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258 [TBL] [Abstract][Full Text] [Related]
17. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG; J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649 [TBL] [Abstract][Full Text] [Related]
18. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing. Tanno K; Ryu S; Watanabe N; Minoura Y; Kawamura M; Asano T; Kobayashi Y; Katagiri T Circulation; 2004 Apr; 109(15):1854-8. PubMed ID: 15066948 [TBL] [Abstract][Full Text] [Related]
19. Microvolt T-wave alternans during atrial and ventricular pacing. Shalaby AA; Voigt A; El-Saed A; Mains M; Shusterman V Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S178-82. PubMed ID: 17302700 [TBL] [Abstract][Full Text] [Related]
20. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]